130 related articles for article (PubMed ID: 31804677)
21. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
[TBL] [Abstract][Full Text] [Related]
22. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
23. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
Zhang HH; Li AH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.
Kodama J; Yoshinouchi M; Seki N; Hongo A; Miyagi Y; Kudo T
Int J Oncol; 1999 Jul; 15(1):149-54. PubMed ID: 10375608
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337
[TBL] [Abstract][Full Text] [Related]
29. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
30. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
Chen J; Zhu J
Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
[TBL] [Abstract][Full Text] [Related]
31. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
32. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
33. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
34. The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.
Wang R; Jiao Y; Li Y; Ye S; Pan G; Qin S; Hua F; Liu Y
Biomed Res Int; 2020; 2020():9519235. PubMed ID: 32420386
[TBL] [Abstract][Full Text] [Related]
35. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
36. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
37. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
38. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Wu WJ; Shen Y; Sui J; Li CY; Yang S; Xu SY; Zhang M; Yin LH; Pu YP; Liang GY
Mol Med Rep; 2018 Jun; 17(6):7845-7858. PubMed ID: 29620291
[TBL] [Abstract][Full Text] [Related]
40. The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer.
Li P; Xu M; Cai H; Thapa N; He C; Song Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
